Published in J Biol Chem on February 02, 1996
Bile pigment pharmacokinetics and absorption in the rat: therapeutic potential for enteral administration. Br J Pharmacol (2011) 0.95
Low solubility of unconjugated bilirubin in dimethylsulfoxide--water systems: implications for pKa determinations. BMC Biochem (2002) 0.90
Biliverdin amides reveal roles for propionate side chains in bilin reductase recognition and in holophytochrome assembly and photoconversion. Biochemistry (2010) 0.87
Revalidation and rationale for high pKa values of unconjugated bilirubin. BMC Biochem (2007) 0.84
Review: Bilirubin pKa studies: new models and theories indicate high pKa values in water, dimethylformamide and DMSO. BMC Biochem (2010) 0.77
Interactions of unconjugated bilirubin with vesicles, cyclodextrins and micelles: new modeling and the role of high pKa values. BMC Biochem (2010) 0.77
Metastable and equilibrium phase diagrams of unconjugated bilirubin IXα as functions of pH in model bile systems: Implications for pigment gallstone formation. Am J Physiol Gastrointest Liver Physiol (2014) 0.75
Bilirubin is an antioxidant of possible physiological importance. Science (1987) 11.26
The ready isomerization of bilirubin IX- in aqueous solution. Biochem J (1972) 2.50
The enzymatic formation of bilirubin. Ann N Y Acad Sci (1975) 2.34
Phytochrome chromophore biosynthesis. Treatment of tetrapyrrole-deficient Avena explants with natural and non-natural bilatrienes leads to formation of spectrally active holoproteins. J Biol Chem (1989) 2.01
The meso-reactivity of porphyrins and related compounds. VI. Oxidative cleavage of the haem system. The four isomeric biliverdins of the IX series. J Chem Soc Perkin 1 (1973) 1.92
Blue light and bilirubin excretion. Science (1980) 1.81
Configurational isomerization of bilirubin and the mechanism of jaundice phototherapy. Biochem Biophys Res Commun (1979) 1.76
The role of singlet oxygen in bilirubin photo-oxidation. Biochem Biophys Res Commun (1971) 1.55
Photobilirubin: an early bilirubin photoproduct detected by absorbance difference spectroscopy. Proc Natl Acad Sci U S A (1979) 1.53
Photodynamic therapy of malignant tumours. Lancet (1972) 1.48
Preparation and properties of crystalline biliverdin IX alpha. Simple methods for preparing isomerically homogeneous biliverdin and [14C[biliverdin by using 2,3-dichloro-5,6-dicyanobenzoquinone. Biochem J (1980) 1.29
Role of hyperbilirubinemia in the impairment of osteoblast proliferation associated with cholestatic jaundice. J Clin Invest (1995) 1.29
Turning green to gold. Nat Struct Biol (2001) 1.27
Phototherapy for neonatal hyperbilirubinemia: efficacy, mechanism and toxicity. Adv Pediatr (1980) 1.17
Hyperbilirubinemia results in reduced oxidative injury in neonatal Gunn rats exposed to hyperoxia. Free Radic Biol Med (1995) 1.14
Degradation of hepatic haem to porphyrins and oxophlorins in rats treated with 2-allyl-2-isopropylacetamide. Biochem Soc Trans (1976) 1.14
Antioxidant activities of bile pigments: biliverdin and bilirubin. Methods Enzymol (1990) 1.11
'Like a shrivelled blood orange'--bilirubin, jaundice, and phototherapy. Pediatrics (1985) 1.10
Evaluating the impact of facilitated communication on the communicative competence of fourteen students with autism. J Autism Dev Disord (1996) 1.08
Jaundice phototherapy: micro flow-cell photometry reveals rapid biliary response of Gunn rats to light. Science (1978) 1.06
Thermal and photochemical reactions of bilirubin IX-alpha. Ann N Y Acad Sci (1975) 1.05
Current therapy for Crigler-Najjar syndrome type 1: report of a world registry. Hepatology (1996) 1.03
Bile pigments as HIV-1 protease inhibitors and their effects on HIV-1 viral maturation and infectivity in vitro. Biochem J (1996) 1.02
Phototherapy for neonatal jaundice: optimal wavelengths of light. J Pediatr (1983) 1.01
Phototherapy of neonatal jaundice. Biochem Soc Trans (1976) 1.00
Oral contraceptives and renal and retinal complications in young women with insulin-dependent diabetes mellitus. JAMA (1994) 0.99
[New synthesis and 14 C-labelling of bilirubin-IXalpha]. Justus Liebigs Ann Chem (1972) 0.97
Photochemotherapy of glioma cells by visible light and hematoporphyrin. Cancer Res (1975) 0.95
Origin of mammalian biliprotein and rearrangement of bilirubin glucuronides in vivo in the rat. J Clin Invest (1984) 0.93
Factors influencing the onset and progression of diabetic retinopathy in subjects with insulin-dependent diabetes mellitus. Ophthalmology (1993) 0.92
Angiotensin-converting enzyme inhibitor therapy and diabetic retinopathy. Ann Ophthalmol (1992) 0.91
Disposition and irreversible plasma protein binding of tolmetin in humans. Clin Pharmacol Ther (1988) 0.91
Physiological characteristics of elite sport parachutists. Aviat Space Environ Med (1985) 0.89
Evidence for covalent binding of acyl glucuronides to serum albumin via an imine mechanism as revealed by tandem mass spectrometry. Proc Natl Acad Sci U S A (1993) 0.88
Evidence for singlet oxygen quenching by biliverdin IX-alpha dimethyl ester and its relevance to bilirubin photo-oxidation. Biochem Biophys Res Commun (1972) 0.87
Aqueous dissociation constants of bile pigments and sparingly soluble carboxylic acids by 13C NMR in aqueous dimethyl sulfoxide: effects of hydrogen bonding. J Lipid Res (1997) 0.87
Synthesis and structure-activity studies of N,N'-diarylguanidine derivatives. N-(1-naphthyl)-N'-(3-ethylphenyl)-N'-methylguanidine: a new, selective noncompetitive NMDA receptor antagonist. J Med Chem (1994) 0.86
Reduction of biliverdin and placental transfer of bilirubin and biliverdin in the pregnant guinea pig. Biochem J (1981) 0.85
Reactivity of tolmetin glucuronide with human serum albumin. Identification of binding sites and mechanisms of reaction by tandem mass spectrometry. Drug Metab Dispos (1995) 0.85
Phototherapy for neonatal jaundice: in vitro comparison of light sources. Pediatr Res (1984) 0.84
Quantum yields for laser photocyclization of bilirubin in the presence of human serum albumin. Dependence of quantum yield on excitation wavelength. Photochem Photobiol (1989) 0.84
Dissociation constants of water-insoluble carboxylic acids by 13C-NMR. pK(a)s of mesobiliverdin-XIII alpha and mesobilirubin-XIII alpha. Experientia (1996) 0.84
Covalent binding of zomepirac glucuronide to proteins: evidence for a Schiff base mechanism. Drug Metab Dispos (1991) 0.84
Tin-protoporphyrin: a potent photosensitizer of bilirubin destruction. Photochem Photobiol (1985) 0.83
Photophysical studies of tin(IV)-protoporphyrin: potential phototoxicity of a chemotherapeutic agent proposed for the prevention of neonatal jaundice. Proc Natl Acad Sci U S A (1988) 0.83
Calculated free bilirubin levels and neurotoxicity. J Perinatol (2009) 0.83
Irreversible binding of zomepirac to plasma protein in vitro and in vivo. J Clin Invest (1986) 0.82
Structure and metabolism of natural and synthetic bilirubins. J Perinatol (2001) 0.82
Heme catabolism in fish. Bile pigments in gallbladder bile of the electric torpedo, Torpedo californicus. Comp Biochem Physiol B (1982) 0.80
Enhanced covalent binding of tolmetin to proteins in humans after multiple dosing. Clin Pharmacol Ther (1994) 0.80
Angiotensin-converting enzyme inhibitor treatment for young normotensive diabetic subjects: a two-year trial. Ann Ophthalmol (1993) 0.80
Novel system for storage of buffy-coat-derived platelet concentrates in a glucose-based platelet additive solution: parameters and metabolism during storage and comparison to plasma. Vox Sang (2009) 0.80
Effect of esterase inhibition on the disposition of zomepirac glucuronide and its covalent binding to plasma proteins in the guinea pig. J Pharmacol Exp Ther (1990) 0.79
Phototherapy: a new twist to bilirubin. J Pediatr (1981) 0.79
Wavelength-dependent quantum yield for Z----E isomerization of bilirubin complexed with human serum albumin. Photochem Photobiol (1992) 0.79
Hypocalcemic cataract. I. An animal model and cation distribution study. Metab Pediatr Ophthalmol (1981) 0.78
Photochemistry and photometabolism in bilirubin IXalpha. Birth Defects Orig Artic Ser (1976) 0.78
Hepatic excretion of circulating bilirubin photoproducts in the Gunn rat. J Clin Invest (1980) 0.78
Expression of growth factor mRNA in rabbit PVR model systems. Curr Eye Res (1992) 0.78
Photochemotherapy and photodynamic toxicity: simple methods for identifying potentially active agents. Biochem Med (1977) 0.78
Irreversible binding of tolmetin glucuronic acid esters to albumin in vitro. Pharm Res (1990) 0.78
Sunlight-induced mutation of bilirubin in a long-distance runner. N Engl J Med (1986) 0.77
The influence of external potassium ions upon lens conductance characteristics investigated using a voltage clamp technique. Exp Eye Res (1980) 0.77
Hypertonic saline compresses: therapy for complicated exit-site infections. Adv Perit Dial (1993) 0.77
Binding of [3H]bilirubin to albumin and plasma membrane vesicles. Biochem J (1997) 0.77
Resolution of a paradox in the electrophoresis of DNA in agarose gels. Electrophoresis (1990) 0.77
Spectacles, ultraviolet radiation, and formation of cataracts. N Engl J Med (1989) 0.76
Synthesis and mass-spectrometric characterization of human serum albumins modified by covalent binding of two non-steroidal anti-inflammatory drugs: tolmetin and zomepirac. Biochem J (1995) 0.76
The meso-reactivity of porphyrins and related compounds. Part VII. Benzoyloxylation of phenylpyrroles and of octaethylporphyrin. J Chem Soc Perkin 1 (1976) 0.76
Short-dwell peritoneal dialysis: increased use and impact on clinical outcome. Adv Perit Dial (1993) 0.76
Photoinduced covalent binding of frusemide and frusemide glucuronide to human serum albumin. Br J Clin Pharmacol (1999) 0.75
Tin-protoporphyrin in the management of children with Crigler-Najjar disease. Pediatrics (1990) 0.75
Pigments in breast fluid. What are they? BMJ (1995) 0.75
Structural volume changes upon photoisomerization of the bilirubin-albumin complex: a laser-induced optoacoustic study. Photochem Photobiol (1998) 0.75
Use of constant target sets in visual search tasks. Percept Mot Skills (1978) 0.75
Pre-spiking dialysate bags: improved peritonitis prevention in patients on CAPD. Adv Perit Dial (1991) 0.75
A flow-cell method for measuring hepatic excretion of pigments continuously in rats. J Pharmacol Methods (1981) 0.75
Stereoselective disposition of naproxen glucuronide in the rat. Drug Metab Dispos (1995) 0.75
Light effects on transport and excretion of bilirubin in newborns. Ann N Y Acad Sci (1985) 0.75
Synthesis and metabolism of the first thia-bilirubin. J Org Chem (2001) 0.75
New concepts in phototherapy. Pediatrics (1981) 0.75
Dialysis adequacy indices in high membrane transporters treated with short-dwell peritoneal dialysis. Adv Perit Dial (1995) 0.75
Inflammation due to surgical glove powders in the rabbit eye. Arch Ophthalmol (1988) 0.75
Kindergarten performance of children born at risk. Can J Psychol (1988) 0.75
Sodium etiobilirubin-IVgamma-C10-sulfonate: a highly solvated bile pigment structure containing two different non-ridge-tile conformers in the unit cell. Bioorg Med Chem Lett (2001) 0.75
An evaluation of the use of spelling error analysis in the diagnosis of reading disabilities. Child Dev (1977) 0.75
Protein-bound bilirubin. N Engl J Med (1983) 0.75
Social policy on the use of aversive interventions: empirical, ethical, and legal considerations. J Autism Dev Disord (1991) 0.75
Letter: Phototherapy and hyperbilirubinaemia. Lancet (1975) 0.75
Searching for multiple targets simultaneously: is it really possible? Percept Mot Skills (1978) 0.75
N-(3-azidophenyl)-N-methyl-N'-([4-1H]- and [4-3H]-1-naphthyl)guanidine. A potent and selective ligand designed as a photoaffinity label for the phencyclidine site of the N-methyl-D-aspartate receptor. Bioconjug Chem (1993) 0.75
Stereoselective binding properties of naproxen glucuronide diastereomers to proteins. J Pharmacokinet Biopharm (1995) 0.75